John Park, PharmD, is an innovative commercial leader currently serving as the US Commercial Director for Vectibix and Lumakras in the Oncology Business Unit at Amgen. With a proven track record of creating and growing healthcare businesses, they have successfully guided products from Phase III through nearly the entirety of their lifecycle. Previously, John held key marketing roles at Baxter Healthcare, PDC, and NeoGenomics Laboratories, and they were the Chief Marketing Officer at NeoGenomics from 2018 to 2020. John earned a BA from the University of California, Santa Barbara, and both an MBA and a PharmD from the University of Southern California.
This person is not in the org chart
This person is not in any teams
This person is not in any offices